This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Jun;69(6):3845-52.
doi: 10.1128/IAI.69.6.3845-3952.2001.

Human antibodies against Plasmodium falciparum liver-stage antigen 3 cross-react with Plasmodium yoelii preerythrocytic-stage epitopes and inhibit sporozoite invasion in vitro and in vivo

Affiliations

Human antibodies against Plasmodium falciparum liver-stage antigen 3 cross-react with Plasmodium yoelii preerythrocytic-stage epitopes and inhibit sporozoite invasion in vitro and in vivo

K Brahimi et al. Infect Immun. 2001 Jun.

Abstract

The Plasmodium falciparum liver-stage antigen 3 (LSA3), a recently identified preerythrocytic antigen, induces protection against malaria in chimpanzees. Using antibodies from individuals with hyperimmunity to malaria affinity purified on recombinant or synthetic polypeptides of LSA3, we identified four non-cross-reactive B-cell epitopes in Plasmodium yoelii preerythrocytic stages. On sporozoites the P. yoelii protein detected has a molecular mass similar to that of LSA3. T-cell epitopes cross-reacting with P. yoelii were also demonstrated using peripheral blood lymphocytes from LSA3-immunized chimpanzees. In contrast, no cross-reactive epitopes were found in Plasmodium berghei. LSA3-specific human antibodies exerted up to 100% inhibition of in vitro invasion of P. yoelii sporozoites into mouse hepatocytes. This strong in vitro activity was reproduced in vivo by passive transfer of LSA3 antibodies. These results indicate that the homologous epitopes may be biologically functional and suggest that P. yoelii could be used as a model to assess the antisporozoite activity of anti-LSA3 antibodies.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Location of the various LSA3 peptides and recombinant proteins. R1, R2, and R3 represent repeat regions. DG729, NN, and PC sequences were expressed as either GST-fused or β-Gal-fused recombinant proteins (see Materials and Methods).
FIG. 2
FIG. 2
Ab reactivity on sporozoite and liver stages. (A) Western blot analysis of 17XNL sporozoites extracts with human Abs immunopurified on the recombinant protein GST-PC (LSA3-Cterm) (lane 1) or human Abs immunopurified on the recombinant protein β-Gal-DG671 (SALSA antigen) used as control (lane 2). Masses are shown in kilodaltons. ∗, reactivity with a 205-kDa polypeptide. IFAT was performed with human anti-β-Gal-DG729 (LSA3-Nterm) immunopurified Abs on P. yoelii sporozoites isolated from salivary glands of infected Anopheles stephensi mosquitoes (B) and on a cryosection of P. yoelii liver schizont (44-h development) obtained in C3H/Hej mice (C). (D) A direct immunofluorescence assay was performed on the suspension injected into mice (Table 3), showing the detachment of the sporozoite membrane induced by anti-LSA3 antibodies upon live P. yoelii sporozoites. White bars, 10 μm.
FIG. 3
FIG. 3
T-cell responses to P. yoelii sporozoite extract. Antisporozoite proliferative responses of lymphocytes from chimpanzee Gerda sampled 4 weeks after the third immunizing dose with lipopeptide LSA3-NRII. PBMC from Gerda were prepared and were incubated with freeze-thawed P. yoelii or P. berghei sporozoites at concentrations ranging from 50 to 5,000 sporozoites per 2 ×ばつ 105 cells (given as x axis). Experimental and control wells were run in triplicate. The results are presented as stimulation indices calculated as the ratio of geometric mean counts per minute from Ag-stimulated cultures to the value from cultures without Ag. The mean background counts per minute of responses in control cultures without Ag was 2,659 for Gerda.
FIG. 4
FIG. 4
In vitro inhibition of hepatocyte invasion by P. yoelii sporozoites. The inhibitory effect of human anti-LSA3 Abs was evaluated upon P. yoelii or P. berghei sporozoite invasion into mice hepatocytes. Abs were affinity purified on the recombinant protein β-Gal-DG729 (LSA3-Nterm) or β-Gal-DG671 (SALSA). Anti-SALSA Abs (α-SALSA) were used as control for human Abs (α-LSA3). The anti-CS MAb of P. berghei was used as control for the P. berghei sporozoite invasion. The human Abs were tested at a concentration corresponding to their IFAT end point titer (1/2). The anti-CS MAb of P. berghei was used at a dilution of 5 ×ばつ 10−4 (IFAT end point titer of 10−6). All samples were tested in duplicate. The number of liver schizonts was counted in each well, and the percentage of inhibition was calculated compared to that for control wells to which no Abs were added. The numbers of P. yoelii and P. berghei liver schizonts in control wells without Abs were 101.5 ± 15.45 and 110.5 ± 21.70, respectively.

References

    1. BenMohamed L, Gras-Masse H, Tartar A, Daubersies P, Brahimi K, Bossus M, Thomas A, Druilhe P. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees. Eur J Immunol. 1997;27:1242–1253. - PubMed
    1. BenMohamed L, Thomas A, Bossus M, Brahimi K, Wubben J, Gras-Masse H, Druilhe P. High immunogenicity in chimpanzees of peptides and lipopeptides derived from four new Plasmodium falciparum pre-erythrocytic molecules. Vaccine. 2000;18:2843–2855. - PubMed
    1. Bottius E, BenMohamed L, Brahimi K, Gras-Masse H, Lepers J P, Aikawa M, Meis J, Slierendregt B, Tartar A, Thomas A, Druilhe P. A novel Plasmodium falciparum sporozoite and liver stage antigen (SALSA) defines major B, Th and CTL epitopes. J Immunol. 1996;156:2874–2884. - PubMed
    1. Brahimi K, Pérignon J L, Bossus M, Gras H, Tartar A, Druilhe P. Fast immunopurification of small amounts of specific antibodies on peptides bound to ELISA plates. J Immunol Methods. 1993;162:69–75. - PubMed
    1. Burns J M, Parke L A, Daly T M, Cavacini L A, Weidanz W P, Long C A. A protective monoclonal antibody recognizes a variant-specific epitope in the precursor of the major merozoite surface antigen of the rodent malarial parasite Plasmodium yoelii. J Immunol. 1989;142:2835–2840. - PubMed

MeSH terms

LinkOut - more resources

Cite

AltStyle によって変換されたページ (->オリジナル) /